Scripps licenses 'click chemistry' to AL biotech; MN pols wine and dine Baxter;

@FierceBiotech: GlaxoSmithKline picks up FDA panel plug for Breo approval. Story | Follow @FierceBiotech

@RyanMFierce: S. Korean biotech Celltrion "drops" late-stage Rituxan biosim. Can you imagine this happening w/ a s. molecule? Nope. Report | Follow @RyanMFierce

> Huntsville, AL-based biotech Serina Therapeutics has licensed "click chemistry" technology from The Scripps Research Institute. Release

> Minnesota politicians aim to lure Baxter International ($BAX) to set up shop in the state with a package of $15.4 million in tax incentives. Article

Pharma News

@FiercePharma: Baxter to put $300M into old Genmab plant in Minnesota. More | Follow @FiercePharma

@EricPFierce: Is your company among the top 10 pharma companies by employees? If so, where does it fall? Story | Follow @EricPFierce

> Safety watchdog flags GLP-1 drugs for pancreatitis reports to FDA. News

> Will Brazil grab the emerging-markets popularity crown? More

> Sanofi embarks on doc-training in Morocco to boost diabetes, epilepsy care. Article

Vaccines News

> H7N9 cases jump, some show resistance to Roche's Tamiflu. More

> Polio eradication push nearing endgame again. Story

> ITS eyes Big Pharma suitors as universal flu vaccine advances. Article

> India's Biological E pentavalent vaccine takes on GSK, J&J. Item

> Vaccine campaign struggling to contain measles outbreak. More

Pharma Manufacturing News

> Issues with contractor leads to shortage of GSK's Horizant. More

> Sanofi expands in Morocco with €20M hub. News

> Canada's Pharmascience opens new distribution center. Story

> Hikma will keep injectables manufacturing. More

> Contaminated capsules dissolve Biostar earnings. Article

Medical Device News

@FierceMedDev: Combat Medical Systems wins $86M govt. contract. Story | Follow @FierceMedDev

@MarkHFierce: Dx development for the developing world is a hot new area, and the U.K.'s Lumora is diving in. More | Follow @MarkHFierce

 @DamianFierce:  Abbott won FDA approval for a new eye implant, part of its efforts to boost sluggish medical device sales. News | Follow @DamianFierce

> EU faulty implant trial gets colorful amid patients' jeers. Story

> Illumina reaches into China with diagnostics partnership. Item

> Baxter infusion pump, dialysis sales rise slowly. More

And Finally… The Wall Street Journal talked to one of the founders of Living Proof, a hair products company with chemical recipes from the lab of MIT biotech inventor Bob Langer. Item (sub. req.)